Paper Details

Paper Title

Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes.

Paper Journal Title

Nat Med

Paper Citation Count

1088

Paper Publication Year

2018

Bio Mention

ABC-DLBCLs, ABC/GCB-independent group, CDKN2A, DLBCL, DLBCLs, Diffuse large B cell lymphoma, GCB, GCB-DLBCLs, TP53, activated B cell (ABC, activated B cell (ABC), coordinate, diffuse large B cell lymphoma, germinal center B cell (GCB) subtypes, lymphoid malignancy, patients

Mesh Descriptor

Author Name	Affiliation
Chip Stewart	Broad Institute of Harvard and Massachusetts Institute of Technology
Chip Stewart	Broad Institute of Harvard and Massachusetts Institute of Technology
Jaegil Kim	Broad Institute of Harvard and Massachusetts Institute of Technology
Atanas Kamburov	Broad Institute of Harvard and Massachusetts Institute of Technology
Michael S Lawrence	Harvard Medical School
Michael S Lawrence	Massachusetts General Hospital
Michael S Lawrence	Broad Institute of Harvard and Massachusetts Institute of Technology
Jeremiah Wala	Broad Institute of Harvard and Massachusetts Institute of Technology
Jeremiah Wala	Broad Institute of Harvard and Massachusetts Institute of Technology
Matthew Ducar	Dana-Farber Cancer Institute, Center for Cancer Genome Discovery
Ignaty Leshchiner	Broad Institute of Harvard and Massachusetts Institute of Technology
Esther Rheinbay	Broad Institute of Harvard and Massachusetts Institute of Technology
Amaro Taylor-Weiner	Broad Institute of Harvard and Massachusetts Institute of Technology
Julian M Hess	Broad Institute of Harvard and Massachusetts Institute of Technology
Julian M Hess	Broad Institute of Harvard and Massachusetts Institute of Technology
Chandra Sekhar Pedamallu	Broad Institute of Harvard and Massachusetts Institute of Technology
Chandra Sekhar Pedamallu	Broad Institute of Harvard and Massachusetts Institute of Technology
Dimitri Livitz	Broad Institute of Harvard and Massachusetts Institute of Technology
Daniel Rosebrock	Broad Institute of Harvard and Massachusetts Institute of Technology
Mara Rosenberg	Broad Institute of Harvard and Massachusetts Institute of Technology
Mara Rosenberg	Broad Institute of Harvard and Massachusetts Institute of Technology
Adam Tracy	Broad Institute of Harvard and Massachusetts Institute of Technology
Paul Van Hummelen	Dana-Farber Cancer Institute, Center for Cancer Genome Discovery
Reiner Siebert	University Ulm
Aaron R Thorner	Dana-Farber Cancer Institute, Center for Cancer Genome Discovery
Matthew Meyerson	Harvard Medical School
Matthew Meyerson	Broad Institute of Harvard and Massachusetts Institute of Technology
Matthew Meyerson	Harvard Medical School
Matthew Meyerson	Broad Institute of Harvard and Massachusetts Institute of Technology
Todd R Golub	Harvard Medical School
Todd R Golub	Broad Institute of Harvard and Massachusetts Institute of Technology
Todd R Golub	Harvard Medical School
Todd R Golub	Broad Institute of Harvard and Massachusetts Institute of Technology
Rameen Beroukhim	Harvard Medical School
Rameen Beroukhim	Broad Institute of Harvard and Massachusetts Institute of Technology
Stefano Monti	Boston University School of Medicine
Donna Neuberg	Harvard Medical School
Donna Neuberg	Dana-Farber Cancer Institute
Gad Getz	Harvard Medical School
Gad Getz	Broad Institute of Harvard and Massachusetts Institute of Technology
Gad Getz	Massachusetts General Hospital
Gad Getz	Harvard Medical School
Gad Getz	Broad Institute of Harvard and Massachusetts Institute of Technology
Gad Getz	Massachusetts General Hospital

1 - 44

Paper Details

Column Actions

Datasets